Keywords: COVID-19, ICU, Remdesivir, Solidarity, Trial, WHO.
[http://dx.doi.org/10.1093/jac/dkaa321] [PMID: 32829390]
[http://dx.doi.org/10.1056/NEJMoa2007764] [PMID: 32445440]
[http://dx.doi.org/10.1093/cid/ciaa1041] [PMID: 32706859]
[http://dx.doi.org/10.2147/DDDT.S261154]
New Emirates Medical Journal
Title:Dubious Results of Remdisivir Ultimately in Solidarity; Diversity of Severity of Illness is Doubtful
Volume: 2
Author(s): Seyed Mohammad Reza Hashemian*, Hamidreza Jamaati, Mostafa Norizadehtazehkand, Majid Malkmohammad, Parisa Adimi and Ali Amirsavadkouhi
Affiliation:
- Iranian Society of Critical Care, Critical Care, Shahid Beheshti University of Medical Sciences, Tehran,Iran
Keywords: COVID-19, ICU, Remdesivir, Solidarity, Trial, WHO.
Export Options
About this article
Cite this article as:
Hashemian Reza Seyed Mohammad*, Jamaati Hamidreza, Norizadehtazehkand Mostafa, Malkmohammad Majid, Adimi Parisa and Amirsavadkouhi Ali, Dubious Results of Remdisivir Ultimately in Solidarity; Diversity of Severity of Illness is Doubtful, New Emirates Medical Journal 2021; 2 (1) . https://dx.doi.org/10.2174/0250688201999201120113151
DOI https://dx.doi.org/10.2174/0250688201999201120113151 |
Print ISSN 0250-6882 |
Publisher Name Bentham Science Publisher |
Online ISSN 0250-6882 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Leukotriene C4 Synthase: Upcoming Drug Target For Inflammation
Current Drug Targets Supersaturation as a Tool For Skin Penetration Enhancement
Current Pharmaceutical Design Kidney Diseases and Chemokines
Current Drug Targets ‘Osteoimmunology' Offers New Perspectives for the Treatment of Pathological Bone Loss
Current Pharmaceutical Design Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- α Inhibitors
Current Pharmaceutical Biotechnology Mitochondria: the Headquarters in Ischemia-Induced Neuronal Death
Central Nervous System Agents in Medicinal Chemistry Role of the Peroxynitrite - Poly (ADP-Ribose) Polymerase Pathway in the Pathogenesis of Liver Injury
Current Pharmaceutical Design Myogenic Tone as a Therapeutic Target for Ischemic Stroke
Current Vascular Pharmacology Lipid Nanoparticles to Deliver miRNA in Cancer
Current Pharmaceutical Biotechnology Ceramide and Apoptosis: Exploring the Enigmatic Connections between Sphingolipid Metabolism and Programmed Cell Death
Anti-Cancer Agents in Medicinal Chemistry Urate Transport: Regulators of Serum Urate Levels in Humans
Current Rheumatology Reviews From the Editors Perspective: Aquaporins to Apoptosis
Current Neurovascular Research The Role for Oxidative Stress in Aberrant DNA Methylation in Alzheimer’s Disease
Current Alzheimer Research Ledipasvir/Sofosbuvir versus Daclatasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Genotype 4 Patients
Current Drug Safety Angiotensin II and the Cardiac Complications of Diabetes Mellitus
Current Pharmaceutical Design Aberrant DNA Methylation of SOCS1 Gene is Not Associated with Resistance to Imatinib Mesylate among Chronic Myeloid Leukemia Patients
Cardiovascular & Hematological Disorders-Drug Targets Synergistic Effect of Inhibitors of MMPs and ROS-dependent Modifications of Contractile Proteins on Protection Hearts Subjected to Oxidative Stress
Current Pharmaceutical Design Antimicrobial Activity of Carvacrol: Current Progress and Future Prospectives
Recent Patents on Anti-Infective Drug Discovery Pathology of Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets The ERK 1 and 2 Pathway in the Nervous System: From Basic Aspects to Possible Clinical Applications in Pain and Visceral Dysfunction
Current Neuropharmacology